Jane P. Hasselby

422 total citations
12 papers, 271 citations indexed

About

Jane P. Hasselby is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Jane P. Hasselby has authored 12 papers receiving a total of 271 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Cancer Research and 3 papers in Surgery. Recurrent topics in Jane P. Hasselby's work include Pancreatic and Hepatic Oncology Research (5 papers), Cancer Genomics and Diagnostics (5 papers) and Genetic factors in colorectal cancer (3 papers). Jane P. Hasselby is often cited by papers focused on Pancreatic and Hepatic Oncology Research (5 papers), Cancer Genomics and Diagnostics (5 papers) and Genetic factors in colorectal cancer (3 papers). Jane P. Hasselby collaborates with scholars based in Denmark, United States and Netherlands. Jane P. Hasselby's co-authors include Laurits J. Holm, Karsten Buschard, Carsten Palnæs Hansen, Astrid Z. Johansen, Benny Vittrup Jensen, Julia S. Johansen, Inna M. Chen, Eric Santoni‐Rugiu, Morten Mau‐Sørensen and Lise Barlebo Ahlborn and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Jane P. Hasselby

12 papers receiving 268 citations

Peers

Countries citing papers authored by Jane P. Hasselby

Since Specialization

Citations

This map shows the geographic impact of Jane P. Hasselby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane P. Hasselby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane P. Hasselby more than expected).

Fields of papers citing papers by Jane P. Hasselby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane P. Hasselby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane P. Hasselby. The network helps show where Jane P. Hasselby may publish in the future.

Co-authorship network of co-authors of Jane P. Hasselby

This figure shows the co-authorship network connecting the top 25 collaborators of Jane P. Hasselby. A scholar is included among the top collaborators of Jane P. Hasselby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane P. Hasselby. Jane P. Hasselby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Copenhagen Prospective Personalized Oncology (CoPPO)—impact of comprehensive genomic profiling in more than 2000 patients in a phase I setting 2025 ·Annals of Oncology ·(unknown), Martin Højgaard, (unknown), Iben Spanggaard, Ulrik Lassen, Lary A. Robinson, (unknown), Frederik Otzen Bagger, (unknown), (unknown), Jane P. Hasselby, Eric Santoni‐Rugiu, Finn Cilius Nielsen, Christina W. Yde, (unknown)	2
2	Circulating immune-related proteins associated with immune checkpoint inhibitor efficacy in patients with pancreatic ductal adenocarcinoma 2024 ·ESMO Open ·(unknown), (unknown), (unknown), (unknown), (unknown), Jane P. Hasselby, (unknown), (unknown), (unknown)	4
3	Randomized phase 2 study of nivolumab with or without ipilimumab in combination with stereotactic body radiotherapy in patients with refractory metastatic pancreatic cancer (CHECKPAC). 2022 ·Journal of Clinical Oncology ·Inna M. Chen, Julia S. Johansen, Susann Theile, Jessica Xin Hjaltelin, (unknown), Søren Brunak, Jane P. Hasselby, Gro Linno Willemoe, Torben Lorentzen, Kasper Madsen, Benny Vittrup Jensen, (unknown), Poul Geertsen, C.F. Behrens, Christian Nolsøe, (unknown), Inge Marie Svane, Dorte Nielsen	1
4	Circulating Protein Biomarkers for Use in Pancreatic Ductal Adenocarcinoma Identification 2021 ·Clinical Cancer Research ·(unknown), Zsófia Sztupinszki, (unknown), Inna M. Chen, Astrid Z. Johansen, Benny Vittrup Jensen, Stig E. Bojesen, Dorte Nielsen, Carsten Palnæs Hansen, Jane P. Hasselby, Kaspar René Nielsen, Zoltán Szállási, Julia S. Johansen	22
5	New Pathogenic Germline Variants in Very Early Onset and Familial Colorectal Cancer Patients 2020 ·Frontiers in Genetics ·(unknown), Majbritt Busk Madsen, Jane Hübertz Frederiksen, Lukas Adrian Berchtold, Christina Therkildsen, Gro Linno Willemoe, Jane P. Hasselby, Friedrik P. Wikman, Henrik Okkels, Anne‐Bine Skytte, Mef Nilbert, Karin Wadt, Anne‐Marie Gerdes, Thomas van Overeem Hansen	19
6	Prognostic impact of Charlson’s Age‐Comorbidity Index and other risk factors in patients with pancreatic cancer 2020 ·European Journal of Cancer Care ·(unknown), Inna M. Chen, Astrid Z. Johansen, Christian Dehlendorff, Benny Vittrup Jensen, Carsten Palnæs Hansen, Jane P. Hasselby, Niels Henrik Holländer, (unknown), Jon Kroll Bjerregaard, Per Pfeiffer, Mette Yilmaz, (unknown), Svend Erik Nielsen, Julia S. Johansen	15
7	Fenofibrate increases very-long-chain sphingolipids and improves blood glucose homeostasis in NOD mice 2019 ·Diabetologia ·Laurits J. Holm, Martin Haupt‐Jorgensen, (unknown), Jane P. Hasselby, Mesut Bilgin, Karsten Buschard	24
8	Clinical value of serum hyaluronan and propeptide of type III collagen in patients with pancreatic cancer 2019 ·International Journal of Cancer ·Inna M. Chen, Nicholas Willumsen, Christian Dehlendorff, Astrid Z. Johansen, Benny Vittrup Jensen, Carsten Palnæs Hansen, Jane P. Hasselby, Stig E. Bojesen, Per Pfeiffer, Svend Erik Nielsen, Niels Henrik Holländer, Mette Yilmaz, M.A. Karsdal, Julia S. Johansen	44
9	Copenhagen Prospective Personalized Oncology (CoPPO)—Clinical Utility of Using Molecular Profiling to Select Patients to Phase I Trials 2018 ·Clinical Cancer Research ·(unknown), Kristoffer Staal Rohrberg, (unknown), Lise Barlebo Ahlborn, Ane Yde Schmidt, Iben Spanggaard, Jane P. Hasselby, Eric Santoni‐Rugiu, Christina W. Yde, Morten Mau‐Sørensen, Finn Cilius Nielsen, Ulrik Lassen	59
10	Abnormal islet sphingolipid metabolism in type 1 diabetes 2018 ·Diabetologia ·Laurits J. Holm, Lars Krogvold, Jane P. Hasselby, Simranjeet Kaur, (unknown), Mark A. Russell, Clayton E. Mathews, Kristian F. Hanssen, Noel G. Morgan, Bobby P. C. Koeleman, Bart O. Roep, Ivan Gerling, Flemming Pociot, Knut Dahl‐Jørgensen, Karsten Buschard	57
11	Goblet Cell Carcinoids: Characteristics of a Danish Cohort of 83 Patients 2015 ·PLoS ONE ·Ingrid Holst Olsen, Nanna Holt Jessen, Seppo W. Langer, Jane P. Hasselby, Henning Grønbæk, Jens Hillingsø, (unknown), Morten Ladekarl, Lene Hjerrild Iversen, Andreas Kjær, Birgitte Federspiel, Ulrich Knigge	22
12	Gastric Signet Ring Cell Carcinoma Presenting as Diffuse, Infiltrating Myositis—A Case Report and Review of the Literature 2013 ·Journal of Gastrointestinal Cancer ·(unknown), Jane P. Hasselby, Lene Bæksgaard	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact